The frailty burden in older patients with advanced lung cancer receiving nonsurgical treatment is high, but the prevalence varies significantly depending on the population and assessment method. Frailty assessment should be individualized and embedded into routine palliative care, and individualized intervention strategies should be developed targeting modifiable risk factors.
Liu et al. (Thu,) studied this question.